Focus
Genomics Investors: Angels and VC Firms
The RaiseHunt database lists 2,722 Genomics investors: 272 angel investors and 2,450 people at 743 firms. Most list Seed and Series A among their stages; the largest hubs are San Francisco, Boston and New York.
Strongest in San Francisco, Boston and New York
- 2,722
- Genomics investors
- 272
- Angel investors
- 2,450
- People at VC/PE firms
- 743
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
2,722 Genomics investors
Showing 121-140
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
 David Berger Partner at Wilson Sonsini Goodrich & Rosati | Palo Alto, United States | Corporate VC | AIClimate | ||
 Andrew Sexton Investor at Illumina | San Diego, United States | Corporate VC | AIHardware | ||
 Gary Bornstein Program Manager at Point72 | New York City, United States | Private equityVenture debt | AIClimate | ||
 Matthew J. Hobson Principal at Catalio Capital Management | New York, United States | Venture capitalVenture debt | AIHealthcare | ||
 Cris De Luca Partner, AI and Digital Investments at Sanofi | Cambridge, United States | Corporate VC | AIHealthcare | ||
 Peter Steelman Partner at Deerfield Management | New York, United States | Private equityVenture capital | AIHealthcare | ||
 Michael Widmann Associate Director, Portfolio Strategy & Analytics at AbbVie | Chicago, United States | Corporate VC | Healthcare | ||
 Marianne Mertens Investment Committee Member at Alzheimer's Drug Discovery Foundation | Munich, Germany | Venture capital | Healthcare | ||
 Dustin Robinson Founder at Iter Investments | Miami Beach, United States | Venture capital | AIClimate | ||
 Jeff Goater Partner at The Column Group | Boston, United States | Venture capital | Healthcare | ||
 Veranika Razhkova Principal at Deerfield Management | New York, United States | Private equityVenture capital | AIHealthcare | ||
 Aaron Vaccaro President at Singularity University | Sacramento, United States | AcceleratorVenture capital | AIConsumer | ||
 Elise Wang Partner at Deerfield Management | New York, United States | Private equityVenture capital | AIHealthcare | ||
 Andrew ElBardissi Partner at Deerfield Management | New York, United States | Private equityVenture capital | AIHealthcare | ||
 Anthony Arceci Biotech Investor at 5AM Ventures | Boston, United States | Venture capital | Healthcare | ||
 Laia Crespo Partner at Sanofi | Paris, France | Corporate VC | AIHealthcare | ||
 Vincent Mellet Partner at Deerfield Management | New York, United States | Private equityVenture capital | AIHealthcare | ||
 Mario Reto Principal at Ampersand Capital Partners | Boston, United States | Private equity | CommerceHardware | ||
 Victor Rusu Principal at MPM BioImpact | Boston, United States | Private equityVenture capital | Healthcare | ||
 Jason P. Hafler Investor at Sanofi | Cambridge, United States | Corporate VC | AIHealthcare |
Data: RaiseHunt investor dataset · Snapshot 16 October 2026 · How this data is built · Report a correction or request removal